Abstract
We previously reported the antibacterial activity of CD437, a known antitumor compound. It proved to be a potent antimicrobial agent effective against both growing and persister cells of methicillin-resistant Staphylococcus aureus (MRSA). Herein, we report the synthesis of a panel of analogs and their effect on both MRSA and cancer cells. The hydrophobic group of the parent compound was varied in steric bulk, and lipid-mimicking analogs were tested. Biological assessment confirmed that the adamantane moiety is the most effective substitution for antibacterial activity, and some preferential action in cancer over MRSA was achieved.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 393-397 |
| Number of pages | 5 |
| Journal | ACS Medicinal Chemistry Letters |
| Volume | 11 |
| Issue number | 3 |
| DOIs | |
| State | Published - Mar 12 2020 |
Keywords
- CD437
- Methicillin resistant Staphylococcus aureus
- cancer
- persister
- retinoid
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry
Divisions
- Infectious Disease
Fingerprint
Dive into the research topics of 'Structure-Activity Relationship and Anticancer Profile of Second-Generation Anti-MRSA Synthetic Retinoids'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS